You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharma
since
auto-detected in 34 stories
6 days ago
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
37 days ago
Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker ○
While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
47 days ago
Pharma stocks are showing strength. Charts predict this name could break out next ⊕
Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within healthcare.
52 days ago
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid ⊕⊕
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.
87 days ago
Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case ⊕
found
a story from The Guardian ⚠️ › International
OxyContin maker to be replaced by new company aiming to combat opioid crisis as legal settlement takes effect
OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on …
88 days ago
Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement ○
Purdue Pharma was sentenced Tuesday to $5.5 billion in fines and penalties on charges of deceiving regulators and paying doctors to boost opioid sales.
Purdue Pharma to pay more than $8bn to end US opioid case ○
Resolution will allow billions of dollars to flow to US cities and states that have been hit by the epidemic
89 days ago
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs ○
Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.
4 months ago
Merck nears $6bn biotech deal to boost cancer drug pipeline ⊖
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
5 months ago
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment ⊕
found
Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.